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Ionizing radiation is a known carcinogen.
Uranium miners are at risk of developing
radiation-related cancer because they are
chronically exposed to alpha particles emitted
by radon and its progeny (henceforth referred
to as radon) and to low levels of whole-body
gamma radiation. Both types of radiation can
cause cellular damage and, in some condi-
tions, induce malignant tumors.
Based on epidemiologic studies in uranium
miners, it has long been recognized that radon
causes lung cancer [National Research Council
(NRC) 1988, 1999; R ˇer ˇicha and S ˇnajberk
1966]. It is unclear whether radon causes other
cancers, including those of the hematopoietic
system. Several ecologic studies (Laurier et al.
2001) reported an association between indoor
radon exposures and leukemia. Myeloid
leukemia and acute lymphocytic leukemia
(ALL) were linked to external radiation in
Japanese atomic bomb survivor studies (Pierce
and Preston 2000; Preston et al. 1994). A
similar association was demonstrated in
patients exposed to therapeutic and diagnostic
irradiation [Hart and Wall 2002; NRC 1990;
Ron 2003; United Nations Scientific
Committee on the Effects of Atomic
Radiation (UNSCEAR) 2000]. Studies in
nuclear worker cohorts show some evidence of
an association with leukemia excluding chronic
lymphocytic leukemia (CLL) (Cardis et al.
2005; Muirhead et al. 1999; Sont et al. 2001;
UNSCEAR 2000). An association of CLL with
radiation exposure has not been demonstrated.
Several issues limit the conclusions that can
be drawn from past epidemiologic studies. The
ecologic studies are methodologically limited,
and their results are inconsistent and uncon-
vincing (Laurier et al. 2001). More rigorous
case–control studies (Law et al. 2000; Lubin
et al. 1998) and cohort studies in uranium
miners (Darby et al. 1995) have not consis-
tently demonstrated increased risks for
hematopoietic malignancies. Studies in atomic
bomb survivors apply to instantaneous uni-
form whole-body external radiation with a
wide range of doses. Therapeutic partial-body
irradiation uses mainly high doses of external
radiation. Diagnostic irradiation usually uses
low external doses; in the case of Thorotrast
(Andersson et al. 1993), a contrast material,
the radiation is internally transmitted by alpha
emitters. Nuclear workers are exposed to pro-
tracted low levels of whole-body external radia-
tion, sometimes combined with internal
exposure to long-lived radionuclides and/or
chemicals. 
Most studies, including all studies of min-
ers, investigated mortality rather than cancer
incidence. Mortality is a good surrogate for
cancer incidence when investigating cancers
with poor survival, such as lung cancer.
However, a substantial number of cases are
likely to be missed in mortality studies of
cancers with low fatality rates, such as CLL.
Some studies (e.g., Dupree-Ellis et al. 2000)
reported only standardized mortality ratios
comparing an occupational cohort with a
general population. Such analyses do not cap-
ture the dose–response relationship well and
are prone to bias because of differences
between the cohort and the population at
large. Other studies lacked sufficient power
because of small numbers of cases or short
follow-up periods (Dupree-Ellis et al. 2000;
Tirmarche et al. 1993). A common problem
is inaccurate or incomplete radiation exposure
measurements (Tomás ˇek and Darby 1995).
The Health Institute of the Uranium
Industry (HIUI) and the National Institute of
Environmental Health Sciences (NIEHS) ini-
tiated a study of cancer incidence in a cohort
of Czech uranium miners exposed to radon
(R ˇer ˇicha et al. 1998). A signiﬁcant increase in
leukemia risk was observed among miners
employed for at least 1 year underground com-
pared with the incidence in the general Czech
population, with a standardized incidence
ratio of 1.58 [95% conﬁdence interval (CI),
1.17–2.16], based on 41 cases. Risk appeared
to increase with increasing radon exposure.
This case–cohort analysis was undertaken to
extend the follow-up period (adding additional
cases), to refine the diagnostic information,
and to improve the estimation of exposures. 
Methods
Uranium mines in the Pr ˇíbram region of the
Czech Republic, about 60 km southwest of
Prague, were the largest in the former
Czechoslovakia. The employment registry of
the Pr ˇíbram Uranium Industry (UI) lists
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OBJECTIVE: Uranium miners are chronically exposed to low levels of radon and its progeny. We
investigated whether radon exposure is associated with increased incidence of leukemia, lymphoma,
or multiple myeloma in this population. 
DESIGN: We conducted a retrospective case–cohort study in 23,043 uranium miners and identiﬁed
a total of 177 incident cases of leukemia, lymphoma, and myeloma. Detailed information on occu-
pational radon exposure was obtained for the cases and a randomly selected subcohort of
2,393 subjects. We used the proportional hazards model with power relative risk (RR) function to
estimate and test the effects of cumulative radon exposures on incidence rates. 
RESULTS: Incidence of all leukemia combined and chronic lymphocytic leukemia (CLL) alone was
positively associated with cumulative radon exposure. The RR comparing high radon exposure
[110 working level months (WLM); 80th percentile] to low radon exposure (3 WLM; 20th per-
centile) was 1.75 [95% conﬁdence interval (CI), 1.10–2.78; p = 0.014] for all leukemia combined
and 1.98 (95% CI, 1.10–3.59; p = 0.016) for CLL. Myeloid leukemia and Hodgkin lymphoma
were also associated with radon, but RRs were not statistically signiﬁcant. There was no apparent
association of radon with either non-Hodgkin lymphoma or multiple myeloma. Exposure to
radon and its progeny was associated with an increased risk of developing leukemia in underground
uranium miners. CLL, not previously believed to be radiogenic, was linked to radon exposure. 
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the Pr ˇíbram mines during the operating
period (1949–1991). Our cohort consisted of
male workers who 1) were listed in the UI
employment registry at any time between
1 January 1949 and 31 December 1975;
2) had registry records indicating that they
had worked underground for at least 1 month
before 1 January 1976; and 3) lived in the
former Czechoslovakia on 1 January 1977.
All 27,441 workers who satisfied criteria 1
and 2 were matched against the National
Registry of Inhabitants and the National
Pension Funds registry to check their vital sta-
tus as of 1 January 1977. The matching suc-
cess rate was 92%. The study cohort included
23,043 male workers who satisfied crite-
ria 1–3. The study protocol was reviewed by
the chair of the Institutional Review Board
(IRB) at the NIEHS and determined to be
exempt from full IRB review because it
involved linkage of existing records and analy-
sis of coded data without identiﬁers. 
Cases and subcohort. This study used a
stratiﬁed case–cohort sampling design. All inci-
dent solid cancers, lymphomas, and myelomas
occurring in the cohort between 1 January
1977 and 31 December 1996, as well as all
incident leukemias occurring between
1 January 1977 and 31 December 2001, were
identiﬁed by matching the 23,043 cohort sub-
jects with the Czech and Slovak national cancer
registries. Reporting of cancer cases to the reg-
istries was mandatory. Study subjects were
matched to the incidence records using unique
government-assigned identiﬁcation numbers. A
total of 2,949 incident cancers of all types were
identified in the cohort; among them were
177 cases of leukemia, lymphoma, or multiple
myeloma. All cancers were recoded according
to the International Classification of Diseases,
Ninth Revision (ICD-9; World Health
Organization 1979). We selected a subcohort
of 2,393 subjects by stratified random sam-
pling. Stratification factors were age on
1 January 1977 (5-year groups) and employ-
ment duration (< 1 year vs. ≥ 1 year).
Subcohort sampling fractions were proportional
to the number of cancer cases identiﬁed in the
stratum, resulting in a subcohort that was, by
design, older than the cohort as a whole
(because cancer cases tended to be older). 
Employment history. The HIUI and the
Uranium Industry Concern provided employ-
ment logs for the cases and the subcohort
subjects. These records contained detailed
work history, including information on exact
duration of employment in different profes-
sions and workplaces, which was used to esti-
mate radiation exposures. Miners could have
worked in one or more professional capaci-
ties, with varying exposures to radiation.
Radon exposure. Individual exposures to
radon for the period 1949–1967 were assigned
using industry tables of mean annual 222Rn
concentrations in picocuries per liter for each
mine. The tables were based on a total of
> 50,000 radon gas measurements systemati-
cally covering locations scattered throughout
the mines. An equilibrium factor was applied
to convert radon gas concentration in pic-
ocuries per liter to the potential alpha energy
of radon progeny. The equilibrium factor val-
ues usually ranged from 0.4 to 0.6; they were
calculated from a series of measurements
taken in the mines, reﬂecting changes in ven-
tilation conditions. The exposure to radon
progeny was calculated from the potential
energy measurement taken in the workplace
during the period of interest, the duration of
the period, and the proportion of working
time spent underground. Since 1968, over
190,000 direct measurements of the potential
alpha energy of radon progeny were obtained.
Radon exposures were converted to working
level months (WLM). A working level is the
concentration of any combination of the
short-lived radon progeny in 1 L of air that
will result in the estimated emission of
1.3 × 105 MeV of potential alpha energy. A
WLM is defined as exposure to 1 WL of
radon for 170 hr.
Other occupational exposures. Since 1966,
individual film badge measurements of
gamma exposure were recorded for a majority
of underground workers. We developed a sta-
tistical model to estimate missing gamma
exposures in the period before 1966 from
annual ore productivity level, calendar year,
number of shifts worked, and profession.
Long-lived radionuclides formed a negligible
part of the total aerial activity; their concentra-
tion in the mine air was < 0.1 Bq/m3. Dust
measurements were recorded monthly for each
workplace. Mean concentrations of airborne
dust reached 10 mg/m3 in the 1950s, dropped
to 2–4 mg/m3 in the 1960s, and later stabi-
lized to < 2 mg/m3. The concentration of
arsenic in Pr ˇíbram ore was low; the average
content of arsenic in samples of load ore was
25 mg/kg, about 200 times less than in
Joachimsthal, another West Bohemian mining
region. The workers were not exposed to
diesel fumes; all underground transportation
used electric power.
Smoking status. The sources of smoking
information were records from job-entry med-
ical examinations taken from HIUI archives
and records from mandatory annual preventive
medical check-ups. The subjects were classiﬁed
as a) never smokers and light smokers who
smoked < 10 cigarettes a day for up to 5 years;
and b) moderate and heavy smokers who
exceeded the limit for light smokers. 
Cancer diagnosis. Hematopoietic cancer
diagnoses reported to the registry were made
by regional hematology specialists using
methods valid at the time of the diagnosis.
After 1990, criteria recommended by the
French–American–British cooperative group,
the International Workshop on CLL, and the
National Cancer Institute Working Group
were used. When hematologists in regional
hospitals could not verify the original diagno-
sis, patients were referred to university hema-
tology departments for immunophenotyping.
Statistical methods. Miners were followed
from 1 January 1977 until the ﬁrst recorded
occurrence of a cancer of interest, death, or
end of follow-up, whichever occurred first.
The end of the follow-up was 31 December
2001 for analyses involving only leukemia
and 31 December 1996 for all other analyses.
Radon exposures were cumulated over the
working histories with a 2-year lag.
In analyses involving risk modeling, cases
received a weight of 1 and subcohort controls
the inverse empirical sampling fraction applica-
ble to their stratum (Borgan et al. 2000). In
categorical analyses, age was categorized into
5-year groups. The number of cases expected
under no exposure effect was calculated from
weighted person-years at age-exposure cells and
observed incidence rates in age groups. The
age-standardized incidence rate was calculated
from observed incidence rates in age-exposure
cells and weighted person-years accrued in age
groups as proportions of the total person-years
for the whole cohort.
The hypothesis of no association between
radiation exposure and cancer incidence was
tested using a proportional hazards model with
age as the time scale and the power relative risk
function RR(y) = (1 + y)β, where y is lagged
cumulative exposure, RR(y) is RR of exposure
y compared with zero, and β is a parameter to
be estimated. We report the estimated effects
in the form of RRs comparing the 80th and
20th percentiles of the distribution of cumula-
tive lifetime exposure in the study population;
that is, RR(y80,y20) = [(1 + y80)/(1 + y20)]β. All
analyses were adjusted for smoking. Exposure
effects were tested using a pseudoscore test. CIs
were based on estimated parameters and their
standard errors. The effect of time since expo-
sure was incorporated by dividing the total
exposure into three exposure variables (expo-
sure acquired 2–15 years ago, 15–25 years ago,
and > 25 years ago).
Parameters in the linear excess RR (ERR)
model were estimated by maximizing
Poisson-like pseudolikelihood for a table clas-
sifying cases and weighted person-years by age
and exposure groups. Separate age effects
were estimated for each age group. This
method yields valid estimates of the linear
ERR parameter but no valid tests or CIs.
There is currently no software to get valid
tests and standard errors for the linear ERR
parameter from a stratiﬁed case–cohort study.
The analyses were done in R (R Foundation
for Statistical Computing, Vienna, Austria)
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Proportional hazards models were ﬁtted using
a Fortran program interfaced to MATLAB.
Primary analyses were verified in SAS (SAS
Institute, Inc., Cary, NC, USA).
Results
Complete exposure and follow-up histories
were determined for 177 cases and 2,393 sub-
cohort subjects. The total study population
was 2,558 because of a small overlap between
the cases and the subcohort. Table 1 shows the
cohort, the subcohort, and the cases classiﬁed
according to the sampling strata. Most workers
in the cohort were ≤ 45 years of age in 1977.
Because of stratiﬁed sampling with respect to
age, the subcohort included relatively older
subjects. The mean age ± SD of the study sub-
jects at the start of follow-up was 50 ± 10.6
years. The median follow-up duration was
18.8 years.
Among hematopoietic malignancies, the
most frequent diagnosis (Table 2) was CLL,
followed by non-Hodgkin lymphoma, multi-
ple myeloma, Hodgkin lymphoma, and other
diagnoses. The average age at diagnosis was
60.1 years (range, 28.4–86.4 years).
The mean ± SD duration of employment
was 6 ± 6.6 years (range, 1 month–39 years).
Over 46% of the workers began employment
before 1955; < 10% were still employed at
the start of follow-up. The mean ± SD life-
time radon exposure was 64.1 ± 98 WLM
(median, 23.2 WLM; range, 0–959 WLM).
Annual radon exposure rates decreased over
time because of improved ventilation and
other protective measures. The mean annual
exposure rate was 29.3 WLM/year in
1949–1955, 11.7 WLM/year in 1956–1965,
2.9 WLM/year in 1966–1975, and 0.7
WLM/year in 1976–1992. Consequently,
younger subjects had much lower radon expo-
sures than older subjects (Table 1). Over 69%
of the subjects were classiﬁed as moderate and
heavy smokers. 
Table 3 shows observed numbers of cases
of each type of cancer by radon exposure cate-
gory, along with the ratio of observed num-
bers and expected numbers under the
assumption of no association of incidence with
exposure. Table 3 also presents incidence rates
standardized to the age distribution of the
whole cohort. For all hematopoietic cancers
combined, there was no consistent pattern in
incidence rates with increasing exposure. For
all leukemia types combined and for CLL, the
rates were not entirely consistent but generally
rose with increasing WLM. 
In proportional hazards analysis, the risk
of all leukemias combined and the risk of CLL
specifically was significantly associated with
radon exposure (Table 4). To evaluate the
associations, we transformed the power risk
parameters to reflect the risks for the upper
exposure quintile (110 WLM) relative to the
lower quintile (3 WLM). These estimated
risks were 1.75 for leukemia and 1.98 for
CLL, with CIs excluding 1. The RR for
Hodgkin lymphoma and myeloid leukemia
was also elevated but was not statistically
significant. Non-Hodgkin lymphoma and
multiple myeloma were not associated with
radon. The analysis of all lymphocytic
leukemias combined is not presented because
this group included only 3 non-CLL cases.
R ˇ er ˇicha et al.
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Table 2. Incidence of diagnoses. 
Follow-up period (no. of cases)
Diagnosis ICD-9 codea 1977–1996 1997–2001 Total
Lymphosarcoma, reticulosarcoma 200 11 —b 11
Hodgkin lymphoma 201 23 —b 23
Non-Hodgkin lymphoma 202 33 —b 33
Multiple myeloma 203 26 —b 26
ALL 204.0 2 0 2
CLL 204.1 40 13 53
Aleukemic leukemia 204.8 1 0 1
Acute myeloid leukemia 205.0 14 2 16
Chronic myeloid leukemia 205.1 7 1 8
Other myeloid leukemia 205.8 0 1 1
Other leukemia 207 2 0 2
Unspeciﬁed leukemia 208 1 0 1
Total — 160 17 177
aWorld Health Organization (1979). bFollow-up was terminated in 1996.
Table 3. Numbers of cases and age-standardized incidence rates by radon exposure category.
Radon (WLM)
Diagnosis (ICD-9 code) 0–5 5–10 10–25 25–50 50–100 > 100 Total
All (200–208)a
Cases 41 22 21 13 24 39 160
O/Eb 0.90 1.19 0.83 0.77 1.15 1.18
Ratec 32.8 47.8 33.5 27.7 39.9 43.3 39.5
Hodgkin lymphoma (201)a
Cases 9 1 42342 3
O/Eb 0.92 0.35 1.14 1.03 1.43 1.43
Ratec 3.3 1.8 5.4 3.7 5.7 3.6 5.0
Non-Hodgkin lymphoma (200, 202)a,d
Cases 18 9 46344 4
O/Eb 1.10 1.66 0.57 1.44 0.65 0.62
Ratec 11.7 16.0 6.0 10.9 4.6 7.1 9.4
Myeloma (203)a
Cases 4 5 41572 6
O/Eb 0.69 1.70 0.98 0.33 1.29 1.11
Ratec 4.7 11.7 6.7 2.1 8.1 6.7 6.7
Leukemia (204–208)
Cases 17 8 12 7 16 24 84
O/Eb 0.76 0.85 0.90 0.75 1.39 1.35
Ratec 13.1 15.3 15.6 13.6 24.2 26.7 17.8
CLL (204.1)
Cases 11 2 6 6 12 16 53
O/Eb 0.82 0.34 0.72 0.99 1.60 1.37
Ratec 9.4 3.9 7.9 10.5 18.8 17.4 11.4
Myeloid leukemia (205)
Cases 5 3 51472 5
O/Eb 0.66 1.06 1.22 0.38 1.27 1.47
Ratec 3.1 5.8 6.6 3.1 5.7 9.0 5.4
aFollow-up ended on 13 December 1996. bObserved number of cases divided by that expected under no exposure effect.
cAge-standardized incidence rate per 100,000 person-years. dIncluding lymphosarcoma/reticulosarcoma.
Table 1. Cohort and subcohort subjects classiﬁed by sampling strata: duration of employment and age and
lifetime radon exposure by age.
Age No. (%) of subjects by duration of employment Mean
groupa ≥ 12 months < 12 months radonb
(years) Cohort Subcohort Cases Cohort Subcohort Cases (WLM)
19–35 6,857 (41.0) 130 (7.1) 23 (17.6) 2,848 (45.0) 103 (18.2) 9 (19.6) 5.9
36–45 3,336 (20.0) 338 (18.5) 19 (14.5) 1,484 (23.5) 135 (23.8) 15 (32.6) 37.4
46–55 4,057 (24.3) 792 (43.4) 57 (43.5) 1,385 (21.9) 234 (41.3) 18 (39.1) 78.4
56–65 1,756 (10.5) 447 (24.5) 28 (21.4) 449 (7.1) 74 (13.1) 1 (2.2) 83.0
66–90 715 (4.3) 119 (6.5) 4 (3.1) 156 (2.5) 21 (3.7) 3 (6.5) 83.7
Total 16,721 (100) 1,826 (100) 131 (100) 6,322 (100) 567 (100) 46 (100) 64.1
aAge on 1 January 1977. bMean lifetime exposure for the cases and subcohort subjects.Separate analyses of ALL and acute and
chronic myeloid leukemia were not performed
because the number of cases was too small.
We used the grouped Poisson model to
estimate linear ERR parameters to compare
the power risk model to the linear ERR
model. RRs from the linear ERR model were
similar but slightly attenuated. For example,
the estimated RR comparing 110 WLM to
3 WLM was 1.46 for all leukemia combined
and 1.63 for CLL (results not shown).
Figure 1 shows that the power model gives
higher radon risk estimates for CLL than the
linear ERR model but has smaller residuals at
the higher exposure groups. Maximized
Poisson pseudolikelihoods for both models
were very close to each other, indicating that
the goodness of ﬁt was about the same.
Possible confounding and effect modiﬁca-
tion by other factors was also investigated.
Calendar year of follow-up, age at the start of
exposure, exposure rates, and year of start of
employment did not affect the incidence rates
or modify the effects of radon exposure.
However, we found that the association of
radon with leukemia and CLL significantly
decreased with time since exposure. For exam-
ple, the estimated RR for CLL comparing
110 WLM with 3 WLM was 1.15 (95% CI,
0.68–1.94; p = 0.61) for exposures acquired
> 25 years ago, 1.93 (95% CI, 1.17–3.19; p =
0.024) for exposures acquired 15–25 years
ago, and 4.20 (95% CI, 1.84–9.61; p = 0.02)
for most recent exposures (2–15 years ago).
Discussion
We found a significant relationship between
cumulative radon exposure and incidence of
leukemia, especially CLL. For myeloid
leukemia and Hodgkin disease, the risk was
elevated but nonsigniﬁcant. We saw no asso-
ciation of radon with the incidence of non-
Hodgkin lymphoma or multiple myeloma. 
Miners are also exposed to gamma radia-
tion, which is associated with non-CLL
leukemia. In the mines, gamma radiation
and radon exposure are correlated, and the
observed risk associated with radon could be
explained by exposure to gamma irradiation.
In our study, the estimated lifetime gamma
exposures were relatively low (mean ± SD,
10.3 ± 14.3 mGy; range, 0–227 mGy) and
highly correlated with cumulative radon
exposures (correlation 0.80 on the log scale).
We did a parallel analysis of gamma exposure
and found a significant association with all
leukemias combined (RR = 1.63; 95% CI,
1.05–2.54; p = 0.03) and CLL (RR = 1.96;
95% CI, 1.12–3.42; p = 0.02) when compar-
ing exposures in the 80th percentile (20 mGy)
to the 20th percentile (1 mGy). This result
seems implausible at this low dose, although
we cannot rule out such an effect, perhaps in
combination with an effect due to radon.
There are two potential alternative explana-
tions: either the elevated risk with gamma
reﬂects the strong correlation with radon, or
our estimates of pre-1966 gamma exposures
were too low. We have no data to verify our
ore-productivity–based estimates of gamma
exposures before 1966. It is unlikely that non-
radiation exposures were responsible for the
observed risk, because the workers in Pr ˇíbram
were not exposed to any other substances sus-
pected of causing leukemia.
Smoking was not associated with any
hematopoietic malignancy and did not appear
to confound the association between radon
and leukemia. The estimated RRs due to
smoking ranged from 0.83 to 1.72 with wide
CIs. Smoking effects could not be evaluated
with much precision because smoking was
very common and our data on smoking were
limited. 
The primary strengths of this study are
a) the use of incidence rather than mortality as
the outcome; b) the completeness and quality
of the national cancer registries; c) the avail-
ability of detailed work histories; d) radon
exposure data based on almost 250,000 radon
measurements in the workplaces; and e) statis-
tical methods that do not lose information by
grouping age and exposures. The case–cohort
design allowed an exceptionally detailed
evaluation of exposures based on employment
logs of the cases and subcohort members.
Beginning follow-up after the end of the
exposure period for most miners made this
study particularly suitable for detecting long-
term effects of exposure. 
This study has several limitations, although
none seem to account for the observed associa-
tion between radon exposure and leukemia.
We had no information on cancer diagnoses
before 1977 and may have missed some cases
of ALL, in particular. Furthermore, someone
with leukemia diagnosed before 1977 could
have entered the study as a subcohort control.
The incidence of CLL would be affected more
than that of other cancers because of the long
survival of CLL patients. Such subjects would
be older, on average, than our study cohort,
and their radon exposures would be higher.
Thus, including many unrecognized pre-1977
CLL cases would bias the observed effect of
radon on CLL downward. In addition, diagno-
sis of CLL can be delayed because the disease
often remains asymptomatic for a long time.
However, all UI workers underwent annual
medical examinations (including blood analy-
ses) during their employment and were also
examined, although less frequently, in retire-
ment. Thus, it is unlikely that a substantial
number of unrecognized CLL cases were
included in the subcohort.
The exposure measurements are subject
to measurement error, which is largest for
high exposures acquired in the early period.
The analyses are not adjusted for exposure
measurement errors. These errors typically
attenuate an existing exposure effect rather
than induce an effect where there is none. It
is reassuring, however, that the exposure
effects were strongest in the most recent
period. The conclusions hold even if the high
exposures acquired in the early mining period
are eliminated.
Many studies of radiation–cancer associa-
tions fit the ERR model with a linear dose–
response relationship. We chose the power
RR model because the linear ERR model
tends to suffer from unreliable standard errors
and poor power (Breslow and Day 1987).
The power RR model does not share the
problems of the ERR model, can be used with
ungrouped data, and provides better power
and more reliable p-values and CIs. The good-
ness of ﬁt was similar for both models. 
In the past, radon was not considered a
potential cause of leukemia because it was
believed that most of its alpha activity was
released in the respiratory tract. However, sev-
eral authors (e.g., Henshaw et al. 1990;
Richardson et al. 1991) have suggested that
radon inhalation may deliver a non-negligible
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Table 4. Associations of radon exposure to inci-
dence of lymphoma, myeloma, and leukemia.
Outcome Cases (n) RR (95%CI)a pb
All 160 1.22 (0.87–1.72) 0.24
Hodgkin lymphoma 23 2.12 (0.81–5.52) 0.12
Non-Hodgkin 44 0.80 (0.46–1.37) 0.4
lymphomac
Myeloma 26 1.03 (0.47–2.27) 0.94
Leukemia 84 1.75 (1.10–2.78) 0.014
CLL 53 1.98 (1.10–3.59) 0.016
Myeloid leukemia 25 1.86 (0.79–4.36) 0.14
The reported RRs compare 110 WLM (80th percentile of
the cumulative lifetime dose) to 3 WLM (20th percentile).
a95% CI based on estimated parameter and SE. bp-Value
for the hypothesis of no exposure effect (RR = 1) based on
pseudoscore test in the power risk model. cIncluding
lymphosarcoma/reticulosarcoma.
Figure 1. Comparison of power RR and linear ERR
fits based on the grouped Poisson model. The
points mark empirical RRs for the exposure groups;
the curves are normalized to compare exposures
with the midpoint of the lowest exposure group
(2.5 WLM).
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ERR modelalpha radiation dose to bone marrow and thus
increase leukemia risk. Inhaled radionuclides
may transmit their alpha activity directly after
reaching bone marrow via the blood stream.
Because of its high solubility in fat, radon gas
itself may concentrate in bone marrow fat cells
and emit alpha particles to the surrounding
hematopoietic stem cells (Allen et al. 1995).
Recently published models that simulated
radiation dose to red bone marrow after
inhalation of radon attributed a much more
important role to radon gas than to radon
progeny (Kendall and Smith 2002). Thus, it is
plausible that radon causes much of the
observed increased risk of leukemia.
Our ﬁndings challenge the idea that CLL
is not radiation related. Although well
accepted, the evidence supporting this notion
is not persuasive (Richardson et al. 2005).
CLL etiology is still unknown, but the patho-
genesis of CLL appears to be similar to other
leukemia subtypes. Genetic alterations, inher-
ited or acquired, are likely to lead to any type
of leukemia. Like other subtypes, CLL is asso-
ciated with speciﬁc chromosome and immune
system alterations. Altered apoptosis is likely
to be involved in CLL leukemogenesis.
Mutations of tumor suppressor genes, espe-
cially p53, and an upregulated expression of
the bcl-2 gene may have an important role in
the inhibition of apoptosis (Irons and
Stillman 1996; Stilgenbauer et al. 2002).
Ionizing radiation produces biologic damage
that may play a role in one or more stages of
the neoplastic process leading to CLL. There
is no evidence from research at the molecular
level that CLL cannot be induced by ionizing
radiation.
CLL is the most frequent type of leukemia
among adults in Western Europe and North
America. It is extremely rare in East Asia.
Therefore, studies of the Japanese atomic
bombing cohorts had limited power to detect
an association with CLL. CLL may remain
asymptomatic for years. Patients often have a
prolonged, nonaggressive course marked only
by a stabilized lymphocytosis in the peripheral
blood and bone marrow. It is not unusual for
CLL to be revealed by chance during a consul-
tation for apparently unrelated disease or dur-
ing a routine examination. Many patients with
CLL require no specific treatment and die
from other diseases typical for old age (Greer
et al. 2003; Henderson et al. 2002). 
Given the characteristics of CLL, a sub-
stantial number of cases will be missed in
studies that rely on death certificates. The
accuracy of death certificates compared with
hospital and autopsy diagnoses in the same
cohort has been shown repeatedly to be poor,
especially for diagnoses with low case-fatality.
For example, Demers et al. (1992) compared
death certiﬁcates and autopsy data and found
that only 2 of 24 autopsy-diagnosed cases
were reported on the death certificates. In
another study, Percy et al. (1990) compared
underlying causes of death based on death
certiﬁcates with hospital diagnoses; only 65%
of death certiﬁcate-based diagnoses were con-
sistent with hospital records. In a study of
deaths among atomic bomb survivors, the
overall agreement between death certificates
and autopsy diagnoses was only 52% (Ron
et al. 1994). Thus, mortality studies investi-
gating diseases with low fatality rates, such as
CLL, are likely to miss exposure effects
because of poor ascertainment of cases and
competing causes of death. All previous stud-
ies of uranium miner cohorts collected only
mortality data based on death certiﬁcates. 
To overcome the limitations of mortality
studies, we studied incidence of hematopoietic
malignancies in uranium miners and found a
significant association between cumulative
radon exposure and incidence of all leukemias,
especially CLL. Our findings support the
hypothesis that CLL is also radiogenic
(Richardson et al. 2005). If this conclusion is
conﬁrmed by future studies, leukemia, includ-
ing CLL, should be considered an occupational
disease in workers with prolonged low-level
exposure to radon and perhaps to other kinds
of radiation.
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